267 related articles for article (PubMed ID: 31492443)
21. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
22. Robust optimization of intensity modulated proton therapy.
Liu W; Zhang X; Li Y; Mohan R
Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
[TBL] [Abstract][Full Text] [Related]
23. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
[TBL] [Abstract][Full Text] [Related]
24. Scenario-based radiation therapy margins for patient setup, organ motion, and particle range uncertainty.
Bokrantz R; Fredriksson A
Phys Med Biol; 2017 Feb; 62(4):1342-1357. PubMed ID: 28114114
[TBL] [Abstract][Full Text] [Related]
25. A deep learning-based approach for statistical robustness evaluation in proton therapy treatment planning: a feasibility study.
Vazquez I; Gronberg MP; Zhang X; Court LE; Zhu XR; Frank SJ; Yang M
Phys Med Biol; 2023 Apr; 68(9):. PubMed ID: 37040785
[No Abstract] [Full Text] [Related]
26. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
An Y; Liang J; Schild SE; Bues M; Liu W
Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of robust optimization plan with partial-arc VMAT for photon volumetric-modulated arc therapy: A phantom study.
Miura H; Ozawa S; Nagata Y
J Appl Clin Med Phys; 2017 Sep; 18(5):97-103. PubMed ID: 28691343
[TBL] [Abstract][Full Text] [Related]
28. Robust beam orientation optimization for intensity-modulated proton therapy.
Gu W; Neph R; Ruan D; Zou W; Dong L; Sheng K
Med Phys; 2019 Aug; 46(8):3356-3370. PubMed ID: 31169917
[TBL] [Abstract][Full Text] [Related]
29. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
30. Robustness evaluation of Intensity Modulated Proton Therapy plans using Dose Volume Population Histogram.
Nguyen TTC; Nguyen BT; Mai NV
Phys Med; 2019 Sep; 65():219-226. PubMed ID: 31525620
[TBL] [Abstract][Full Text] [Related]
31. Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude.
Taasti VT; Hattu D; Vaassen F; Canters R; Velders M; Mannens J; van Loon J; Rinaldi I; Unipan M; van Elmpt W
Med Phys; 2021 Aug; 48(8):4425-4437. PubMed ID: 34214201
[TBL] [Abstract][Full Text] [Related]
32. Variable planning margin approach to account for locoregional variations in setup uncertainties.
Yang J; Garden AS; Zhang Y; Zhang L; Dong L
Med Phys; 2012 Aug; 39(8):5136-44. PubMed ID: 22894439
[TBL] [Abstract][Full Text] [Related]
33. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
34. A numerical simulation of organ motion and daily setup uncertainties: implications for radiation therapy.
Killoran JH; Kooy HM; Gladstone DJ; Welte FJ; Beard CJ
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):213-21. PubMed ID: 9054898
[TBL] [Abstract][Full Text] [Related]
35. Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy.
Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
Br J Radiol; 2020 Mar; 93(1107):20190573. PubMed ID: 31778315
[TBL] [Abstract][Full Text] [Related]
36. Adequate margins for random setup uncertainties in head-and-neck IMRT.
Astreinidou E; Bel A; Raaijmakers CP; Terhaard CH; Lagendijk JJ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):938-44. PubMed ID: 15708278
[TBL] [Abstract][Full Text] [Related]
37. Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.
van Dijk LV; Steenbakkers RJ; ten Haken B; van der Laan HP; van 't Veld AA; Langendijk JA; Korevaar EW
PLoS One; 2016; 11(3):e0152477. PubMed ID: 27030987
[TBL] [Abstract][Full Text] [Related]
38. Convolution method and CTV-to-PTV margins for finite fractions and small systematic errors.
Gordon JJ; Siebers JV
Phys Med Biol; 2007 Apr; 52(7):1967-90. PubMed ID: 17374922
[TBL] [Abstract][Full Text] [Related]
39. Volumetric modulated arc therapy with robust optimization for larynx cancer.
Miura H; Doi Y; Ozawa S; Nakao M; Ohnishi K; Kenjo M; Nagata Y
Phys Med; 2019 Feb; 58():54-58. PubMed ID: 30824150
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of clinical margins via simulation of patient setup errors in prostate IMRT treatment plans.
Gordon JJ; Crimaldi AJ; Hagan M; Moore J; Siebers JV
Med Phys; 2007 Jan; 34(1):202-14. PubMed ID: 17278506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
